Table 2 Information of the tumors and the RE procedures in each of the three patients.

From: A proof-of-concept study of the in-vivo validation of a computational fluid dynamics model of personalized radioembolization

Patient

Tumor name

Tumor volume (ml)

Activity (GBq)

k2,s (ml/min/100 ml)a

k*1,s (ml/min/100 ml)b

Segment location by MeVIS

Injection velocity (m/s)

Comments

Patient 1

1a

11.64

0.19

54.7

6.9

Segment 2

0.684

Two injections for tumor 1a and one injection for tumors 1b, 1c, 1d, and 1e

0.19

Segment 3

0.778

1b

2.81

0.8

40.2

6.2

Segment 8

2.01

1c

2.67

39.3

4.2

Segments 7 and 8

2.01

1d

6.22

38.3

2.3

Segment 7

2.01

1e

15.65

41.4

5.0

Segment 7

2.01

Patient 2

2a

2.53

0.50

36.7

3.1

Segment 7

0.52

One injection per tumor

2b

4.47

0.20

42.7

5.2

Segment 8

0.45

Patient 3

3a

63.87

0.82

96.7

12.0

Segments 5, 6 and 7

1.85

One injection for the three tumors

3b

8.92

129.4

11.4

Segment 8

1.85

3c

6.21

103.4

11.9

Segments 7 and 8

1.85

  1. aTumoral arterial perfusion.
  2. bHealthy parenchyma arterial perfusion.